Gene therapy shows promise
Researchers at Beth Israel Deaconess Medical Center are describing a promising treatment for patients with rheumatoid arthritis.
A study published in the February issue of the journal Human Gene Therapy reports the first clinical evidence of the benefits of gene therapy in reducing symptoms in patients with rheumatoid arthritis.
This is an important milestone for the promising treatment which has endured a sometimes turbulent past. The study looks at findings involving two patients with severe rheumatoid arthritis conducted in Germany and led by an investigator at BIDMC.
For more details, click here.